Members |
acceptabilityId |
23-valente-Pneumokokken-Konjugatimpfung |
Acceptable (foundation metadata concept) |
23-valenter Konjugatimpfstoff gegen Pneumokokken |
Preferred (foundation metadata concept) |
23-valenter-Pneumokokken-Konjugatimpfstoff |
Acceptable (foundation metadata concept) |
2p21-Mikrodeletionssyndrom ohne Cystinurie |
Preferred (foundation metadata concept) |
3-4x/Woche |
Acceptable (foundation metadata concept) |
3-4x/w |
Acceptable (foundation metadata concept) |
3-Hydroxy-3-Methylglutarazidurie |
Preferred (foundation metadata concept) |
3-Hydroxy-3-Methylglutaryl-CoA-Synthase-Mangel |
Preferred (foundation metadata concept) |
3-Hydroxy-Isobuttersäure-Krankheit |
Preferred (foundation metadata concept) |
3-Hydroxyacyl-CoA-Dehydrogenase-Mangel |
Preferred (foundation metadata concept) |
3-Methylcrotonyl-CoA-Carboxylase-Mangel, isolierter |
Preferred (foundation metadata concept) |
3-Methylglutaconazidurie |
Preferred (foundation metadata concept) |
3-Methylglutaconazidurie Typ 1 |
Preferred (foundation metadata concept) |
3-Methylglutaconazidurie Typ 3 |
Preferred (foundation metadata concept) |
3-Methylglutaconazidurie Typ 4 |
Preferred (foundation metadata concept) |
3-Methylglutaconazidurie Typ 7 |
Preferred (foundation metadata concept) |
3-Methylglutaconazidurie Typ 8 |
Preferred (foundation metadata concept) |
3-Methylglutaconazidurie Typ 9 |
Preferred (foundation metadata concept) |
3-Phosphoglycerat-Dehydrogenase-Mangel, infantile/juvenile Form |
Preferred (foundation metadata concept) |
3-Phosphoserin-Phosphatase-Mangel, infantile/juvenile Form |
Preferred (foundation metadata concept) |
3-Tage-Fieber |
Acceptable (foundation metadata concept) |
3. Schwangerschaft |
Preferred (foundation metadata concept) |
3. Trimester |
Preferred (foundation metadata concept) |
3/60 Sehschärfe des linken Auges |
Acceptable (foundation metadata concept) |
3/60 Sehschärfe des rechten Auges |
Acceptable (foundation metadata concept) |
3/60 Visus des linken Auges |
Preferred (foundation metadata concept) |
3/60 Visus des rechten Auges |
Preferred (foundation metadata concept) |
3C-Syndrom |
Preferred (foundation metadata concept) |
3M-Syndrom |
Preferred (foundation metadata concept) |
3MC-Syndrom |
Preferred (foundation metadata concept) |
3TC - Lamivudin |
Acceptable (foundation metadata concept) |
4 bis 6 Mal täglich |
Acceptable (foundation metadata concept) |
4,4'-Methylendiphenyldiisocyanat |
Acceptable (foundation metadata concept) |
4. Schwangerschaft |
Preferred (foundation metadata concept) |
4/60 Sehschärfe des linken Auges mit Korrektur |
Acceptable (foundation metadata concept) |
4/60 Sehschärfe des rechten Auges mit Korrektur |
Acceptable (foundation metadata concept) |
4/60 Visus des linken Auges mit Korrektur |
Preferred (foundation metadata concept) |
4/60 Visus des rechten Auges mit Korrektur |
Preferred (foundation metadata concept) |
45,X/46,XY-Gonadendysgenesie, gemischte |
Preferred (foundation metadata concept) |
46,XX Störung der Geschlechtsentwicklung-anorektale Anomalien-Syndrom |
Preferred (foundation metadata concept) |
46,XX testikuläre Störung der Geschlechtsentwicklung |
Preferred (foundation metadata concept) |
46,XY-Gonadendysgenesie, partielle |
Preferred (foundation metadata concept) |
46,XY-Gonadendysgenesie, vollständige |
Preferred (foundation metadata concept) |
46,XY-Störung der Geschlechtsentwicklung |
Preferred (foundation metadata concept) |
47,XYY-Syndrom |
Preferred (foundation metadata concept) |
48,XXXY-Syndrom |
Preferred (foundation metadata concept) |
48,XXYY-Syndrom |
Preferred (foundation metadata concept) |
48,XYYY-Syndrom |
Preferred (foundation metadata concept) |
49,XXXXY-Syndrom |
Preferred (foundation metadata concept) |
49,XXXYY-Syndrom |
Preferred (foundation metadata concept) |
49,XYYYY-Syndrom |
Preferred (foundation metadata concept) |
4H-Leukodystrophie |
Preferred (foundation metadata concept) |
5'-Nukleotidase im Serum erhöht |
Acceptable (foundation metadata concept) |
5'-Nukleotidase im Serum erniedrigt |
Acceptable (foundation metadata concept) |
5'-Nukleotidase im Serum innerhalb Referenzbereich |
Preferred (foundation metadata concept) |
5'-Nukleotidase im Serum oberhalb Referenzbereich |
Preferred (foundation metadata concept) |
5'-Nukleotidase im Serum unter Referenzbereich |
Acceptable (foundation metadata concept) |
5'-Nukleotidase im Serum unterhalb Referenzbereich |
Preferred (foundation metadata concept) |
5'-Nukleotidase im Serum über Referenzbereich |
Acceptable (foundation metadata concept) |
5-ALA |
Acceptable (foundation metadata concept) |
5-Amino-4-Imidazolcarboxamid-Ribosidurie |
Preferred (foundation metadata concept) |
5-Amino-4-oxopentansäure |
Acceptable (foundation metadata concept) |
5-Aminolävulinsäure |
Preferred (foundation metadata concept) |
5-Azacytidin |
Acceptable (foundation metadata concept) |
5-Fluorouracil-Vergiftung |
Preferred (foundation metadata concept) |
5-HIES (5-Hydroxyindolessigsäure) im Urin erhöht |
Acceptable (foundation metadata concept) |
5-Hydroxyindolessigsäure im Urin erhöht |
Acceptable (foundation metadata concept) |
5-Hydroxyindolessigsäure im Urin oberhalb Referenzbereich |
Preferred (foundation metadata concept) |
5-Hydroxyindolessigsäure im Urin über Referenzbereich |
Acceptable (foundation metadata concept) |
5-Hydroxyindolessigsäure in Urinprobe erhöht |
Acceptable (foundation metadata concept) |
5-Hydroxyindolylessigsäure im Urin erhöht |
Acceptable (foundation metadata concept) |
5-Oxoprolinase-Mangel |
Preferred (foundation metadata concept) |
5-Ureidohydantoin |
Acceptable (foundation metadata concept) |
5. Schwangerschaft |
Preferred (foundation metadata concept) |
5/60 Sehschärfe des linken Auges mit Korrektur |
Acceptable (foundation metadata concept) |
5/60 Sehschärfe des rechten Auges mit Korrektur |
Acceptable (foundation metadata concept) |
5/60 Visus des linken Auges mit Korrektur |
Preferred (foundation metadata concept) |
5/60 Visus des rechten Auges mit Korrektur |
Preferred (foundation metadata concept) |
6 Meter |
Preferred (foundation metadata concept) |
6-Phosphogluconat-Dehydrogenase-Mangel |
Preferred (foundation metadata concept) |
6. Schwangerschaft |
Preferred (foundation metadata concept) |
6/12 Sehschärfe des linken Auges |
Acceptable (foundation metadata concept) |
6/12 Sehschärfe des linken Auges mit Lochblende |
Acceptable (foundation metadata concept) |
6/12 Sehschärfe des rechten Auges |
Acceptable (foundation metadata concept) |
6/12 Sehschärfe des rechten Auges mit Lochblende |
Acceptable (foundation metadata concept) |
6/12 Visus des linken Auges |
Preferred (foundation metadata concept) |
6/12 Visus des linken Auges mit Lochblende |
Preferred (foundation metadata concept) |
6/12 Visus des rechten Auges |
Preferred (foundation metadata concept) |
6/12 Visus des rechten Auges mit Lochblende |
Preferred (foundation metadata concept) |
6/15 Sehschärfe des linken Auges |
Acceptable (foundation metadata concept) |
6/15 Sehschärfe des rechten Auges |
Acceptable (foundation metadata concept) |
6/15 Visus des linken Auges |
Preferred (foundation metadata concept) |
6/15 Visus des rechten Auges |
Preferred (foundation metadata concept) |
6/18 Sehschärfe des linken Auges |
Acceptable (foundation metadata concept) |
6/18 Sehschärfe des linken Auges mit Lochblende |
Acceptable (foundation metadata concept) |
6/18 Sehschärfe des rechten Auges |
Acceptable (foundation metadata concept) |
6/18 Sehschärfe des rechten Auges mit Lochblende |
Acceptable (foundation metadata concept) |
6/18 Visus des linken Auges |
Preferred (foundation metadata concept) |
6/18 Visus des linken Auges mit Lochblende |
Preferred (foundation metadata concept) |
6/18 Visus des rechten Auges |
Preferred (foundation metadata concept) |
6/18 Visus des rechten Auges mit Lochblende |
Preferred (foundation metadata concept) |